Newsroom
Jump to:
Press Releases
January 7, 2026
Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer
Truvian today announced the appointment of Michael J. Mina, MD, PhD as Chief Medical and Strategy Officer to oversee clinical and regulatory strategy, while advancing strategic partnerships and opportunities.
December 2, 2025
Truvian Secures FDA Clearance for TruVerus™, Setting a New Standard in Multimodal Blood Testing
Truvian today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K251058) for TruVerus™, the industry’s first multimodal blood testing benchtop instrument.
January 13, 2025
David P. King joins Truvian’s Advisory Board
Truvian today announced the appointment of David P. King to its Advisory Board. King brings decades of diagnostics and business experience with a distinguished track record of advancing innovation and shaping corporate strategy.
